Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px

Person › Details

David Veitch (Basilea Pharmaceutica International Ltd.)

Veitch, David (Basilea 201804– CEO before CCO since 201408 before Savient + BMS)

	Organisation	Basilea Pharmaceutica International Ltd.
	Group	Basilea (Group)
	Former/major organisation	Savient Pharmaceuticals Inc.
	Product	Zevtera™ (ceftobiprole medocaril)
	Product 2	isavuconazole

Record changed: 2024-04-07

Picture biomindz TRON LSG Mainz Translation Cancer Immunotherapy 650x200px

More documents for David Veitch

[1] Basilea Pharmaceutica Ltd.. (4/4/24). "Press Release: Basilea Announces US FDA Approval of Antibiotic Zevtara (ceftobiprole medocaril) for Three Indications". Allschwil....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)